David Ward is a co-founder of Michel & Ward, P.C., a general practice law firm in Chattanooga, Tennessee. David’s practice concentrates on medical malpractice litigation, nursing home litigation, drug and pharmaceutical issues and argument at all appellate levels. With 26 years of litigation experience, David’s practice features trials including:
- Defense Verdict – Alleged wrongful death in failure to diagnose and treat acute fatty liver disease
- Defense Verdict – Alleged wrongful death in failure to properly perform lung cancer surgery
- Defense Verdict – Alleged wrongful death in failure to diagnose and treat myocardial infarction
- Defense Verdict – Alleged wrongful death in failure to diagnose and treat pulmonary disease
- Defense Verdict – Alleged wrongful death in failure to diagnose and treat colon cancer
- Defense Verdict – Alleged failure to properly perform ulnar nerve surgery on hand
- Defense Verdict – Alleged failure properly construct restaurant building
- Summary Judgment – Alleged discrimination in HIV treatment case
Through his litigation practice, David became aware of the common pattern in the medical community of prescribing painkilling opioids as the frontline medication for everyday pain, a practice which has led to the unnecessary addiction and death of countless Americans. Realizing that this problem, which has now been recognized as an epidemic by the Centers of Disease Control, can only slowed by re-education of healthcare providers regarding the appropriate use for these powerful drugs, David has spoken about this problem and potential solutions to various groups including the American Society of Medical Association Counsel, The Tennessee Medical Association, The University of Tennessee College of Pharmacy, Blue Cross Blue Shield of Tennessee, East Tennessee Children’s Hospital, and the Tennessee Pharmacist’s Association. Additionally, David has also authored and/or co-authored several articles on Rx Drug Diversion and has been honored to be an invited speaker and moderator at National Rx Drug Abuse Summit I, II & III.
